Evaluation of B-cell Abnormalities in Infants of Breastfeeding Mothers on anti-CD20 Therapies for Multiple Sclerosis

被引：0
|
作者：
Shah, Anna [1 ]
Alvarez, Enrique [1 ]
机构：
[1] Univ Colorado, Denver, CO USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000204239
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S31.001
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [32] Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Lehmann-Horn, Klaus
    Schleich, Eva
    Hertzenberg, Deetje
    Hapfelmeier, Alexander
    Kuempfel, Tania
    von Bubnoff, Nikolas
    Hohlfeld, Reinhard
    Berthele, Achim
    Hemmer, Bernhard
    Weber, Martin S.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2011, 8
  • [33] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [34] Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma
    Peter, N.
    Zoellner, A. K.
    Zimmermann, Y.
    Hutter, G.
    Hiddemann, W.
    Dreyling, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 72 - 72
  • [35] B-cell depletion by anti-CD20 antibody treatment in rheumatoid arthritis modulates the B-cell repertoire.
    Rouzière, AS
    Kneitz, C
    Dörner, T
    Tony, HP
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S138 - S138
  • [36] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    [J]. ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [37] Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
    Florou, Despoina
    Katsara, Maria
    Feehan, Jack
    Dardiotis, Efthimios
    Apostolopoulos, Vasso
    [J]. BRAIN SCIENCES, 2020, 10 (10) : 1 - 13
  • [38] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Finn Sellebjerg
    Morten Blinkenberg
    Per Soelberg Sorensen
    [J]. CNS Drugs, 2020, 34 : 269 - 280
  • [39] Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Klaus Lehmann-Horn
    Eva Schleich
    Deetje Hertzenberg
    Alexander Hapfelmeier
    Tania Kümpfel
    Nikolas von Bubnoff
    Reinhard Hohlfeld
    Achim Berthele
    Bernhard Hemmer
    Martin S Weber
    [J]. Journal of Neuroinflammation, 8
  • [40] Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
    Cotchett, Kelly R.
    Dittel, Bonnie N.
    Obeidat, Ahmed Z.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
12345